International Molecular Tumor Board Explores Personalized Treatment Strategies for a Patient with Multiple Primary Cancers
July 22, 2026
“This case underscores the complexity of managing MPC and highlights the essential role of international molecular tumor boards in generating innovative, tailored treatment recommendations for patients with rare and multifaceted… read more